In the wake of an FDA letter warning of civil and criminal liabilities for drug reimportation, American pharmacists are being urged to resist offers to partner with Canadian pharmacies serving U.S. seniors.
How Differences in Bispecific Therapies Impact Myeloma Treatment Operations
April 18th 2024According to Kirollos Hanna, PharmD, although similarities exist between bispecific therapies in the myeloma space, health care providers should take special note of practical differences and nuances associated with each when operationalizing them at their site of care.